NM_001737.5:c.355T>G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001737.5(C9):āc.355T>Gā(p.Cys119Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000189 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001737.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000318 AC: 80AN: 251298Hom.: 0 AF XY: 0.000339 AC XY: 46AN XY: 135834
GnomAD4 exome AF: 0.000194 AC: 284AN: 1461876Hom.: 0 Cov.: 32 AF XY: 0.000193 AC XY: 140AN XY: 727246
GnomAD4 genome AF: 0.000138 AC: 21AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74318
ClinVar
Submissions by phenotype
Complement component 9 deficiency Pathogenic:1Uncertain:1
- -
- -
Complement component 9 deficiency;C3810042:Age related macular degeneration 15 Uncertain:2
- -
C9 NM_001737.4 exon 4 p.Cys119Gly (c.355T>G): This variant has been reported in the literature in 1 individual with complement C9 deficiency as a compound heterozygote, in trans with a loss-of-function variant (p.Ser427*). Both of these variants were implied to segregate with disease in 1 affected family member (Witzel-Schlomp 1998 PMID:9634479). This variant is present in 0.2% (22/10360) of Ashkenazi Jewish alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/5-39341369-A-C?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:17042). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In addition, in vitro functional studies predict that this variant will impact the protein (Witzel-Schlomp 1998 PMID:9634479). However, these studies may not accurately represent in vivo biological function. Of note, splice prediction tools suggest that this variant may affect splicing. However, further studies are needed to understand its impact. In summary, data on this variant is highly suspicious for disease, but requires further evidence for pathogenicity. Therefore, the clinical significance of this variant is uncertain. -
not provided Pathogenic:1
This sequence change replaces cysteine, which is neutral and slightly polar, with glycine, which is neutral and non-polar, at codon 119 of the C9 protein (p.Cys119Gly). This variant is present in population databases (rs121909593, gnomAD 0.2%). This missense change has been observed in individual(s) with C9 deficiency (PMID: 9634479). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as Cys98Gly. ClinVar contains an entry for this variant (Variation ID: 17042). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt C9 protein function with a positive predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at